Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Biguanides × 30 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

pembrolizumab 162 Carboplatin 123 Paclitaxel 85 Cisplatin 79 Gemcitabine 71 Pemetrexed 66 Bevacizumab 60 Cyclophosphamide 50 Docetaxel 47 Oxaliplatin 41 Nivolumab 39 Fluorouracil 39 durvalumab 38 Dexamethasone 38 Fulvestrant 36 Cetuximab 35 Capecitabine 35 130-nm albumin-bound paclitaxel 35 Lenalidomide 33 Leucovorin 31 fludarabine 30 atezolizumab 30 Rituximab 30 Prednisone 29 venetoclax 27 Trastuzumab 24 Doxorubicin 23 Letrozole 22 ribociclib 20 enzalutamide 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05663515 2026-03-19

EXCEED

AstraZeneca

24,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡